--- title: "Hong Kong stock movement: TH MEDICAL-B plummets 23.73%, lack of catalysts leads investors to be cautious" type: "News" locale: "en" url: "https://longbridge.com/en/news/293170076.md" description: "TH MEDICAL-B fell 23.73%; MicroPort Scientific Corporation-B rose 3.09%, with a transaction volume of HKD 91.9 million; MicroPort Medical rose 3.60%, with a transaction volume of HKD 85.43 million; Angelalign rose 4.90%, with a transaction volume of HKD 38.17 million; Diligent-B fell 6.37%, with a market value of HKD 24 billion" datetime: "2026-07-20T06:16:35.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/293170076.md) - [en](https://longbridge.com/en/news/293170076.md) - [zh-HK](https://longbridge.com/zh-HK/news/293170076.md) generator: "portal-rs" --- # Hong Kong stock movement: TH MEDICAL-B plummets 23.73%, lack of catalysts leads investors to be cautious **Hong Kong Stock Movement** TH MEDICAL-B fell 23.73%. Based on recent key news: 1. On July 18, Broncus Holding-B lacked short-term catalysts, leading healthcare investors to adopt a wait-and-see approach. Due to a lack of confidence in the company's future development, investors chose to temporarily exit, resulting in a significant drop in stock price. 2. On July 18, macroeconomic changes affected China Everbright Bank's credit issuance speed, exacerbating market concerns about the financial industry. The uncertainty in the credit market made investors cautious about related stocks, impacting overall market sentiment. 3. On July 18, the net asset value of iShares Asia ex-Japan ETF saw a significant decline in mid-July, reflecting increased volatility in markets outside Japan. Changes in capital flows led to weakened investor confidence in regional markets, affecting the performance of related stocks. Macroeconomic changes influenced market sentiment. **Stocks with High Trading Volume in the Industry** MicroPort Scientific-B rose 3.09%. Based on recent news, 1. On July 17, the healthcare industry sentiment was sluggish, and trading volume rapidly shrank, limiting the rebound. Although MicroPort Scientific-B's stock price increased, changes in market sentiment and trading volume may affect its subsequent performance. The healthcare industry's sentiment is low, with significant changes in trading volume. MicroPort Medical rose 3.60%. Based on recent news, 1. On July 17, tightened listing standards on the STAR Market led to the suspension of IPOs for several medical companies. Under financial pressure, MicroPort Medical actively sought new financing channels to support R&D and commercialization, driving up its stock price. 2. On July 16, MicroPort Medical announced it had secured a new round of financing, with funds to be used for overseas market expansion, enhancing investor confidence and subsequently increasing its stock price. 3. On July 15, the overall industry performed strongly, with the medical device sector receiving policy support. MicroPort Medical benefited from optimistic market sentiment, leading to a rise in its stock price. The medical device industry received clear policy support, with significant capital inflows. Angelalign rose 4.90%, with a trading volume of HKD 38.17 million, and there has been no significant news recently. The trading is active, with clear capital flows. Considering the sector and industry trends, this stock shows significant volatility, and the specific reasons need further observation. **Stocks with High Market Capitalization in the Industry** Daxit-B fell 6.37%. Based on recent key news: 1. On July 19, Yilian Biotech submitted a listing application for B7-H3 ADC, promoting the development of the innovative drug market. Yilian Biotech's Icotinib monoclonal antibody achieved positive results in Phase III clinical trials and received multiple breakthrough therapy designations and orphan drug qualifications. Yilian Biotech reached an exclusive licensing agreement with Roche, which will be responsible for global development and commercialization, and Yilian Biotech will receive upfront and milestone payments. This move may impact Daxit-B's market competitiveness 2. On July 19, the Ministry of Ecology and Environment and five other departments jointly issued the "14th Five-Year Plan for the Protection of Soil, Groundwater, and Agricultural and Rural Ecological Environment," proposing the trend and prospects of the "Beautiful Countryside +" multi-dimensional integration new business model. This plan emphasizes the shift in rural construction towards a value enhancement based on high-quality ecology and deep integration of multiple industries, which may affect the market strategies of related enterprises. 3. Recently, there are no other important news. The competition in the innovative drug market is intensifying, and ecological policies are having an impact ### Related Stocks - [02697.HK](https://longbridge.com/en/quote/02697.HK.md) - [02252.HK](https://longbridge.com/en/quote/02252.HK.md) - [00853.HK](https://longbridge.com/en/quote/00853.HK.md) - [06699.HK](https://longbridge.com/en/quote/06699.HK.md) - [02526.HK](https://longbridge.com/en/quote/02526.HK.md) ## Related News & Research - [Guangdong True Health signs sales contract worth up to RMB 100 million](https://longbridge.com/en/news/297484935.md) - [Guangdong True Health signs strategic cooperation pact with General Technology Liaoning Pharmaceutical](https://longbridge.com/en/news/296881513.md) - [09:01 ETHealthcare Is Moving Into the Home. Home Accessibility Now Has a Validated Score.](https://longbridge.com/en/news/297656740.md) - [13:30 ETViventium Launches Next Generation Workforce Management Platform for Healthcare](https://longbridge.com/en/news/297815495.md) - [Microsoft survey finds 97% of healthcare leaders say data silos hinder timely care delivery](https://longbridge.com/en/news/297807480.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**